In the current study we had developed and characterized Poly (lactic-co-glycolide) acid nanoparticles for anticancer drug Doxorubicin and further studied in-vitro cytotoxic effect of free and encapsulated nanoparticle drug delivery system. PLGA-drug nanoparticles were prepared by oil-water emulsion solvent evaporation method. The morphology of drug loaded nanoparticles was analyzed using a scanning electron microscope. The drug loaded nanoparticles were evaluated for cell cytotoxicity by sulforhodamine B assay. Images of formulation indicate the surface morphology of formulation. The in vitro cytotoxicity results showed Doxorubicin NPs to be active against A431 and NCI-H322 cell line compared to Doxorubicin free drug. The IC50 values were found to be 1.73 µM with A431 cell line whereas 1.64 µM for NCI-H322 cell line. This indicates that Doxorubicin NPs have more pronounced activity towards A431cell line.
Introduction
Cancer is the second largest health problem of the world after cardiovascular diseases in both developed and developing countries. Nanoparticles provide a range of new opportunities to increase the targeting of currently approved diagnostic and therapeutic agents to cancer. Nanoparticles (NPs) carrying a chemotherapeutic can reduce the undesirable distribution of such agents. Nanoparticles integrated with the therapeutic agents can either freely release these agents or undergo their own decomposition for the release to occur.
Improved in targeting can lead not only to increased efficiency of these agents but also to increase signal-to-noise ratio for diagnostics and better efficacy to toxicity ratios for therapeutics. Nanoparticles can access specific sites by avoiding the systemic clearance by the RES system. In the current study we had developed & characterized
Poly (lactic-co-glycolide) acid (PLGA) nanoparticles for anticancer drug Doxorubicin and further studied in-vitro cytotoxic effect of free and encapsulated nanoparticle drug delivery system.
Materials and Methods

Materials
The cell lines were obtained from National Center for Cell Science, Ganeshkhind, Pune-4111007 (India).
Preparation of drug loaded nanoparticles
PLGA-Doxorubicin nanoparticles (NPs) were prepared by oil-water 
Scanning electron microscopy (SEM) analysis
The morphology of drug loaded nanoparticles was analyzed using a SEM, scanning electron microscope. Samples were prepared from dilutions in distilled water of particle suspensions and dropped onto stubs. After air drying, particle were coated with a thin layer of gold and then examined by scanning electron microscopy. 
Cell cytotoxicity evaluation by (sulforhodamine B) SRB assay
Statistics analysis
The data were reported as mean values ± standard deviation (SEM).
Values representing the concentrations of investigated test sample and free drug sample that cause 50% of inhibition (IC50) were determined by the linear regression analysis.
Results and Discussions
Scanning electron microscopy analysis
Parashar et al. Doxorubicin PLGA Nanoparticles UK J Pharm & Biosci, 2013: 1(1); 50 SEM was performed for particles much smaller than 1 μm to be measured. Images of formulation indicate the surface morphology of formulation (Fig 1) .
Determination of cellular cytotoxicity by SRB assay
SRB assay was performed to determine the in-vitro cytotoxicity against adherent cell lines (Table 1) The in vitro cytotoxicity results showed Doxorubicin NPs to be active against both above used cell lines compared to Doxorubicin free drug (Table 1) . In order to have a better insight into the comparative data the IC50 values (the drug concentration at which 50% of growth inhibition takes place) of Doxorubicin NPs against these two cell lines was calculated. The IC50 values were found to be 1.73 µM with A431 cell line (Fig 2) whereas 1.64 µM for NCI-H322 cell line (Fig 3) . This indicates that Doxorubicin NPs have more pronounced activity towards A431cell line.
The above studies lead to a conclusion that, Doxorubicin PLGA NPs are better formulation than free Doxorubicin as supported by the IC50 value. Values are means ± SEM of six determinations 
